Quick Takeaways
- Samir R. Patel filed SCHEDULE 13D/A for Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX).
- Disclosed ownership: 10%.
- Date of event: 02 Mar 2026.
Samir R. Patel - 02 Mar 2026 SCHEDULE 13D/A Report for Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX)
- Filing Manager
- Samir R. Patel
- Reporting Manager
- Samir R. Patel
- Symbol
- AKTX
- Shares outstanding
- 93,511,682,692 shares
- Disclosed Ownership
- 9,725,215,000 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Mar 2026, 16:44:49 UTC
- Date of event
- 02 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Samir R. Patel disclosed 10% ownership in Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX) on 02 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Mar 2026, 16:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samir R. Patel | 10% | 9,725,215,000 | 9,725,215,000 | 0 | /s/ Samir R. Patel | Samir R. Patel, Authorized Signatory | 0001702447 |